ipilimumab,dabrafenib,trametinib,nivolumab
bms,novartis
['dreamseq']
 dr. michael atkins from spoke with us about the #asco22 abstract - dreamseq phase 3 study, qol and symptom analysis in with braf-mutant mm. #oncotwitter 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.